Evidence map›Paper›PMID 8870643›Full record

ArticleThe Biochemical journal1996

Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils.

W H Waterman, T F Molski, C K Huang, J L Adams, R I Sha'afi

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Distinct Mechanisms of Type 3 Secretion System Recognition Control LTBbioRxiv : the preprint server for biology · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2008
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. 5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

W H WatermanDepartment of Physiology, University of Connecticut Health Center, Farmington 06030, USA.
T F Molski
C K Huang
J L Adams
R I Sha'afi
UConn Health · USNew Frontier · US

Funding

CHEMOTACTIC NEUTROPHIL ACTIVATION AND PHOSPHOPROTEINSR01AI020943 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HUANG, CHI-KUANG · 1985 to 2001
$482k
GRANULOCYTE/MACROPHAGE COLONY STIMULATING FACTORR01AI028810 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SHA'AFI, RAMADAN I. · 1992 to 1994
–
CALCIUM AND PLATELET ACTIVATING FACTOR ACTIONR01HL053786 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SHA'AFI, RAMADAN I. · 1994 to 1996
–
NHLBI NIH HHS HL-53786-06NIAID NIH HHS AI-20943NIAID NIH HHS AI-28810-03
6 · The paper itself

Abstract

The role of the newly identified p38 mitogen-activated protein kinase (MAP kinase) in terminally differentiated cells, such as human neutrophils, is totally unknown. In order to examine the possible role of this MAP kinase in the phosphorylation and activation of cytoplasmic phospholipase A2 (cPLA2), we tested the effect of the recently synthesized inhibitor of p38 MAP kinase, SB 203580, on the phosphorylation and activation of both p38 MAP kinase and cPLA2. We found that while tumour necrosis factor-alpha (TNF-alpha)-stimulated tyrosine phosphorylation of p38 MAP kinase is affected only slightly by SB 203580, its stimulated kinase activity is greatly reduced in human neutrophils in suspension treated with this inhibitor. Furthermore, the TNF-alpha-stimulated phosphorylation and activation of cPLA2 are completely abolished in cells treated with SB 203580. Based on these data, it is reasonable to conclude that an SB 203580-sensitive kinase, or kinases and/or phosphatases, are involved in the phosphorylation and activation of cPLA2 in intact human neutrophils in suspension stimulated by TNF-alpha. The possible role of the p38 MAP kinase cascade in the phosphorylation and activation of cPLA2 is discussed.

Indexed as

JNK Mitogen-Activated Protein KinasesMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesCalcium-Calmodulin-Dependent Protein KinasesCytosolEnzyme ActivationEnzyme InhibitorsHumansImidazolesMAP Kinase Kinase 4Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Neutrophilsp38 Mitogen-Activated Protein KinasesPhospholipases APhospholipases A2Calcium-Calmodulin-Dependent Protein KinasesEnzyme InhibitorsImidazolesJNK Mitogen-Activated Protein KinasesMAP Kinase Kinase 4Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase KinasesMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesPhospholipases APhospholipases A2Protein KinasesPyridinesSB 203580Tumor Necrosis Factor-alpha

Identifiers

PMID8870643
PMCPMC1217729
OpenAlexW1831558236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.